Insights into the Industry
The allergy immunotherapy industry has been witnessing optimal growth in recent years and is likely to continue even in upcoming years. The growth of allergy immunotherapy ’s industry size can be attributed to rising investments in research & development activities, entry of new players, product innovation, technological breakthroughs, effective allocation of resources, and growing competition among business rivals to expand its regional as well as customer base. Supportive government policies and incentives, as well as favorable laws, are projected to determine the growth of the allergy immunotherapy market in foreseeable future. An increase in the spending capacity of customers with the rise in disposable income will further contribute towards allergy immunotherapy 's market proceeds.
This market research report is a comprehensive overview of the events taking place in the allergy immunotherapy industry and impacting its growth. Our report divides the allergy immunotherapy market into various segments or categories based on products, applications, region, etc. Additionally, our research analysts have listed the key players of the global allergy immunotherapy market and compared them based on metrics such as market revenue, Y-O-Y sales, shipments volume, historical data, and successful implementation of business strategies such as strategic alliances, mergers & acquisitions, joint ventures, product development, and partnerships & collaborations.
Market Research Store (MRS) published a brand new report titled “Allergy Immunotherapy Market research report which is segmented by Products (Subcutaneous Immunotherapy, Sublingual Immunotherapy), by Applications (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Others), by Key Players/Companies ALK, HAL Allergy Group, Merck KGaA（Allergopharma）, Stallergenes Greer, Circassia, DBV Technologies., Aimmune Therapeutics, Biomay AG, Anergis, Allergy Therapeutics”. In 2020, the global allergy immunotherapy market value was registered at XX (USD Million/Billion) and is predicted to reach XX (USD Million/Billion) at a CAGR of XX% by 2028.
Request Free SampleScope of the report
| Report Attributes | Report Details |
|---|---|
| Report Title | Allergy Immunotherapy Market Research Report |
| By Products | Subcutaneous Immunotherapy, Sublingual Immunotherapy |
| By Applications | Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Others |
| By Key Players | ALK, HAL Allergy Group, Merck KGaA（Allergopharma）, Stallergenes Greer, Circassia, DBV Technologies., Aimmune Therapeutics, Biomay AG, Anergis, Allergy Therapeutics |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East And Africa (MEA) |
| Countries Covered | North America : U.S and Canada Europe : U.K, Spain, Germany, Italy, Russia, France, Rest of Europe APAC : Japan, India, China, Australia, South Korea, South East Asia, Rest of Asia Pacific Latin America : Mexico, Brazil The Middle East And Africa : South Africa, UAE, Saudi Arab, Rest of MEA |
| Base Year | 2020 |
| Historical Year | 2016to 2020 (Depending on availability, data from 2010 can be offered) |
| Forecast Year | 2028 |
| Number of Pages | 111 |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
Based on these findings, the global allergy immunotherapy industry study suggests strategies to existing market participants as to how they can improve & reinforce their market position. In addition to this, the study also recommends successful market penetrating strategies for new entrants. Furthermore, allergy immunotherapy industry study report has included all major manufacturers and distributors operating in the allergy immunotherapy market across all major regions.
Allergy Immunotherapy Market Strategic Analysis
Various analytical methods such as Porter’s Five Force Analysis, SWOT analysis, Market Share Analysis, Competitive Analysis, PESTEL Analysis, Market Attractiveness Analysis, and Value Chain Analysis have been used to analyze the market in the research report. These assessments help users of the report in examining and evaluating allergy immunotherapy market on the basis of different metrics such as switching costs, economies of scale, current sales, brand loyalty, brand equity, capital investments, production rights, research & development activities, copyrights & patents, legislations, effects of promotional activities, and consumer preferences.
The information provided in our market research report is anticipated to help the industry stakeholders in the effective decision-making process and successful business outcomes. Moreover, we have been using Ansoff Matrix to help firms analyze and plan their business growth strategies.
Additionally, our report contains a growth-share matrix that aids firms’ business decisions for prioritizing their myriad businesses. We have also included GE Nine Cell Matrix that is helpful in making strategic planning and can help firms in determining their position in the market along with analyzing their growth strategies.
Our researchers also make use of the perceptual map to demonstrate how to target consumers feel about a given brand and form perception about it. We have also included the Customer-Based Brand Equity (CBBE) Model for helping firms effectively position their brands.
Allergy Immunotherapy Market Key Trends Analysis
The key factors influencing the growth of the allergy immunotherapy market have been assessed in the report. Factors having a huge influence on market demand and restraining factors that impact the development of the market are both addressed rigorously & in-depth in our global market research report.
Furthermore, trends that play a key role in market’s growth are discussed comprehensively in the report. Moreover, a large number of qualitative factors or measurements are included in the report and this includes operating risks and major obstacles encountered by players in the industry.
Allergy Immunotherapy Market Key Segment Analysis
The report delivers a critical assessment on the allergy immunotherapy market by segmenting it based on Products, Applications, and region. All the segments and categories of the allergy immunotherapy market have been evaluated based on past, present and future trends and are key parameters determining & defining the growth of the market.
The data for the market and its segments and categories are provided from 2016 to 2028. The report has identified the key segments and categories contributing substantially towards overall market growth in terms of revenue & volume.
Based on Products, the global allergy immunotherapy market is segmented into Subcutaneous Immunotherapy, Sublingual Immunotherapy. Comprehensive qualitative and quantitative this segment analysis will be provided in the report from 2016 to 2028.
Based on Applications, market is divided into Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Others. A slew of business growth opportunities and dynamics affecting the different segments are analyzed and discussed in the report.
Impact Assessment of COVID-19
The COVID-19 outbreak has wreaked havoc on worldwide economic and social systems. The disease has entered several industries' value and supply chains, including the allergy immunotherapy market. The government imposed lockdowns in various locations. We will examine the impact of the COVID-19 pandemic on the global market, looking at both demand and supply.
The COVID-19 pandemic's short- and long-term impacts would be explored to provide a summary. This would help build business plans for all market participants, including manufacturers, vendors, suppliers, distributors, and end-users, during and after the epidemic.
Allergy Immunotherapy Market Regional Trends and Market Player’s Analysis
On the basis of region, the market is segregated into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa.
The major players holding a huge chunk of market share in the global allergy immunotherapy market and impacting market profitability are evaluated after considering their product & services revenue, sales, business plans, innovations, and growth rate. The final position of a player in the market depends on market events or market happenings, new product launches, mergers & acquisitions, benchmarking, regional expansions, and technical innovations.
For all the key stakeholders of the market, value chain and technology ecosystem, as well as the information provided in this market research report, will prove beneficial. The study offers an outline of the company’s market share and an extensive summary of the major players in the allergy immunotherapy market.
Some of the leading players profiled in the global allergy immunotherapy market are,
- ALK
- HAL Allergy Group
- Merck KGaA（Allergopharma）
- Stallergenes Greer
- Circassia
- DBV Technologies.
- Aimmune Therapeutics
- Biomay AG
- Anergis
- Allergy Therapeutics
The Key Audiences for Allergy Immunotherapy Market Report
- Research Institutes & consulting firms
- Industry Leaders, as well as companies, aspiring to enter the allergy immunotherapy market
- Student and universities
- Solution Providers, product providers, service providers, and other players in the industry
- Associated private firms and government bodies
- Individuals interested to learn about market
The report segments of the global allergy immunotherapy market are as follows:
Global Allergy Immunotherapy Market: By Products
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
Global Allergy Immunotherapy Market: By Applications
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
The Most Important Research Methodologies
Primary sources include industry experts from management corporations, processing organizations, and analytical service providers who serve businesses across the sector's value chain. We interviewed key sources to acquire qualitative and quantitative data and analyse future prospects.
Primary research undertaken for this report comprised interviews with industry professionals such as CEOs, Vice Presidents, Marketing Directors and Technology Directors of strong core organizations and institutions in major allergy immunotherapy . We interviewed them to get qualitative and quantitative data.
The following are the justifications for purchasing the global Allergy Immunotherapy market report:
- Statistical data is well-referenced, and the source is a significant resource for directing interested companies.
- Market development trends and marketing channels that are cutting-edge are discussed.
- The feasibility and growth rate of the market as a whole over the foreseeable future are determined.
- The competitive landscape and demographic research provide a clear picture of the current state of the market on an international scale.
- A thorough examination of development policies and plans, manufacturing processes, and costing provides a more accurate picture of import/export consumption, supply and demand, pricing, revenue, and gross margins, among other things.
- Customization is possible based on the client's requirements.
Frequently Asked Questions
- ALK
- HAL Allergy Group
- Merck KGaA（Allergopharma）
- Stallergenes Greer
- Circassia
- DBV Technologies.
- Aimmune Therapeutics
- Biomay AG
- Anergis
- Allergy Therapeutics
Table Of Content
Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Allergy Immunotherapy Market Share by Type (2020-2026) 1.5.2 Subcutaneous Immunotherapy 1.5.3 Sublingual Immunotherapy 1.6 Market by Application 1.6.1 Global Allergy Immunotherapy Market Share by Application (2020-2026) 1.6.2 Allergic Rhinitis 1.6.3 Asthma 1.6.4 Food Allergy 1.6.5 Venom Allergy 1.6.6 Others 1.7 Allergy Immunotherapy Industry Development Trends under COVID-19 Outbreak 1.7.1 Global COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on Allergy Immunotherapy Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 2.4 Industry Trends Under COVID-19 3 Value Chain of Allergy Immunotherapy Market 3.1 Value Chain Status 3.2 Allergy Immunotherapy Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Allergy Immunotherapy 3.2.3 Labor Cost of Allergy Immunotherapy 3.2.3.1 Labor Cost of Allergy Immunotherapy Under COVID-19 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 3.5 Value Chain Status Under COVID-19 4 Players Profiles 4.1 ALK 4.1.1 ALK Basic Information 4.1.2 Allergy Immunotherapy Product Profiles, Application and Specification 4.1.3 ALK Allergy Immunotherapy Market Performance (2015-2020) 4.1.4 ALK Business Overview 4.2 HAL Allergy Group 4.2.1 HAL Allergy Group Basic Information 4.2.2 Allergy Immunotherapy Product Profiles, Application and Specification 4.2.3 HAL Allergy Group Allergy Immunotherapy Market Performance (2015-2020) 4.2.4 HAL Allergy Group Business Overview 4.3 Merck KGaA（Allergopharma） 4.3.1 Merck KGaA（Allergopharma） Basic Information 4.3.2 Allergy Immunotherapy Product Profiles, Application and Specification 4.3.3 Merck KGaA（Allergopharma） Allergy Immunotherapy Market Performance (2015-2020) 4.3.4 Merck KGaA（Allergopharma） Business Overview 4.4 Stallergenes Greer 4.4.1 Stallergenes Greer Basic Information 4.4.2 Allergy Immunotherapy Product Profiles, Application and Specification 4.4.3 Stallergenes Greer Allergy Immunotherapy Market Performance (2015-2020) 4.4.4 Stallergenes Greer Business Overview 4.5 Circassia 4.5.1 Circassia Basic Information 4.5.2 Allergy Immunotherapy Product Profiles, Application and Specification 4.5.3 Circassia Allergy Immunotherapy Market Performance (2015-2020) 4.5.4 Circassia Business Overview 4.6 DBV Technologies. 4.6.1 DBV Technologies. Basic Information 4.6.2 Allergy Immunotherapy Product Profiles, Application and Specification 4.6.3 DBV Technologies. Allergy Immunotherapy Market Performance (2015-2020) 4.6.4 DBV Technologies. Business Overview 4.7 Aimmune Therapeutics 4.7.1 Aimmune Therapeutics Basic Information 4.7.2 Allergy Immunotherapy Product Profiles, Application and Specification 4.7.3 Aimmune Therapeutics Allergy Immunotherapy Market Performance (2015-2020) 4.7.4 Aimmune Therapeutics Business Overview 4.8 Biomay AG 4.8.1 Biomay AG Basic Information 4.8.2 Allergy Immunotherapy Product Profiles, Application and Specification 4.8.3 Biomay AG Allergy Immunotherapy Market Performance (2015-2020) 4.8.4 Biomay AG Business Overview 4.9 Anergis 4.9.1 Anergis Basic Information 4.9.2 Allergy Immunotherapy Product Profiles, Application and Specification 4.9.3 Anergis Allergy Immunotherapy Market Performance (2015-2020) 4.9.4 Anergis Business Overview 4.10 Allergy Therapeutics 4.10.1 Allergy Therapeutics Basic Information 4.10.2 Allergy Immunotherapy Product Profiles, Application and Specification 4.10.3 Allergy Therapeutics Allergy Immunotherapy Market Performance (2015-2020) 4.10.4 Allergy Therapeutics Business Overview 5 Global Allergy Immunotherapy Market Analysis by Regions 5.1 Global Allergy Immunotherapy Sales, Revenue and Market Share by Regions 5.1.1 Global Allergy Immunotherapy Sales by Regions (2015-2020) 5.1.2 Global Allergy Immunotherapy Revenue by Regions (2015-2020) 5.2 North America Allergy Immunotherapy Sales and Growth Rate (2015-2020) 5.3 Europe Allergy Immunotherapy Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Allergy Immunotherapy Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Allergy Immunotherapy Sales and Growth Rate (2015-2020) 5.6 South America Allergy Immunotherapy Sales and Growth Rate (2015-2020) 6 North America Allergy Immunotherapy Market Analysis by Countries 6.1 North America Allergy Immunotherapy Sales, Revenue and Market Share by Countries 6.1.1 North America Allergy Immunotherapy Sales by Countries (2015-2020) 6.1.2 North America Allergy Immunotherapy Revenue by Countries (2015-2020) 6.1.3 North America Allergy Immunotherapy Market Under COVID-19 6.2 United States Allergy Immunotherapy Sales and Growth Rate (2015-2020) 6.2.1 United States Allergy Immunotherapy Market Under COVID-19 6.3 Canada Allergy Immunotherapy Sales and Growth Rate (2015-2020) 6.4 Mexico Allergy Immunotherapy Sales and Growth Rate (2015-2020) 7 Europe Allergy Immunotherapy Market Analysis by Countries 7.1 Europe Allergy Immunotherapy Sales, Revenue and Market Share by Countries 7.1.1 Europe Allergy Immunotherapy Sales by Countries (2015-2020) 7.1.2 Europe Allergy Immunotherapy Revenue by Countries (2015-2020) 7.1.3 Europe Allergy Immunotherapy Market Under COVID-19 7.2 Germany Allergy Immunotherapy Sales and Growth Rate (2015-2020) 7.2.1 Germany Allergy Immunotherapy Market Under COVID-19 7.3 UK Allergy Immunotherapy Sales and Growth Rate (2015-2020) 7.3.1 UK Allergy Immunotherapy Market Under COVID-19 7.4 France Allergy Immunotherapy Sales and Growth Rate (2015-2020) 7.4.1 France Allergy Immunotherapy Market Under COVID-19 7.5 Italy Allergy Immunotherapy Sales and Growth Rate (2015-2020) 7.5.1 Italy Allergy Immunotherapy Market Under COVID-19 7.6 Spain Allergy Immunotherapy Sales and Growth Rate (2015-2020) 7.6.1 Spain Allergy Immunotherapy Market Under COVID-19 7.7 Russia Allergy Immunotherapy Sales and Growth Rate (2015-2020) 7.7.1 Russia Allergy Immunotherapy Market Under COVID-19 8 Asia-Pacific Allergy Immunotherapy Market Analysis by Countries 8.1 Asia-Pacific Allergy Immunotherapy Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Allergy Immunotherapy Sales by Countries (2015-2020) 8.1.2 Asia-Pacific Allergy Immunotherapy Revenue by Countries (2015-2020) 8.1.3 Asia-Pacific Allergy Immunotherapy Market Under COVID-19 8.2 China Allergy Immunotherapy Sales and Growth Rate (2015-2020) 8.2.1 China Allergy Immunotherapy Market Under COVID-19 8.3 Japan Allergy Immunotherapy Sales and Growth Rate (2015-2020) 8.3.1 Japan Allergy Immunotherapy Market Under COVID-19 8.4 South Korea Allergy Immunotherapy Sales and Growth Rate (2015-2020) 8.4.1 South Korea Allergy Immunotherapy Market Under COVID-19 8.5 Australia Allergy Immunotherapy Sales and Growth Rate (2015-2020) 8.6 India Allergy Immunotherapy Sales and Growth Rate (2015-2020) 8.6.1 India Allergy Immunotherapy Market Under COVID-19 8.7 Southeast Asia Allergy Immunotherapy Sales and Growth Rate (2015-2020) 8.7.1 Southeast Asia Allergy Immunotherapy Market Under COVID-19 9 Middle East and Africa Allergy Immunotherapy Market Analysis by Countries 9.1 Middle East and Africa Allergy Immunotherapy Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Allergy Immunotherapy Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Allergy Immunotherapy Revenue by Countries (2015-2020) 9.1.3 Middle East and Africa Allergy Immunotherapy Market Under COVID-19 9.2 Saudi Arabia Allergy Immunotherapy Sales and Growth Rate (2015-2020) 9.3 UAE Allergy Immunotherapy Sales and Growth Rate (2015-2020) 9.4 Egypt Allergy Immunotherapy Sales and Growth Rate (2015-2020) 9.5 Nigeria Allergy Immunotherapy Sales and Growth Rate (2015-2020) 9.6 South Africa Allergy Immunotherapy Sales and Growth Rate (2015-2020) 10 South America Allergy Immunotherapy Market Analysis by Countries 10.1 South America Allergy Immunotherapy Sales, Revenue and Market Share by Countries 10.1.1 South America Allergy Immunotherapy Sales by Countries (2015-2020) 10.1.2 South America Allergy Immunotherapy Revenue by Countries (2015-2020) 10.1.3 South America Allergy Immunotherapy Market Under COVID-19 10.2 Brazil Allergy Immunotherapy Sales and Growth Rate (2015-2020) 10.2.1 Brazil Allergy Immunotherapy Market Under COVID-19 10.3 Argentina Allergy Immunotherapy Sales and Growth Rate (2015-2020) 10.4 Columbia Allergy Immunotherapy Sales and Growth Rate (2015-2020) 10.5 Chile Allergy Immunotherapy Sales and Growth Rate (2015-2020) 11 Global Allergy Immunotherapy Market Segment by Types 11.1 Global Allergy Immunotherapy Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global Allergy Immunotherapy Sales and Market Share by Types (2015-2020) 11.1.2 Global Allergy Immunotherapy Revenue and Market Share by Types (2015-2020) 11.2 Subcutaneous Immunotherapy Sales and Price (2015-2020) 11.3 Sublingual Immunotherapy Sales and Price (2015-2020) 12 Global Allergy Immunotherapy Market Segment by Applications 12.1 Global Allergy Immunotherapy Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Allergy Immunotherapy Sales and Market Share by Applications (2015-2020) 12.1.2 Global Allergy Immunotherapy Revenue and Market Share by Applications (2015-2020) 12.2 Allergic Rhinitis Sales, Revenue and Growth Rate (2015-2020) 12.3 Asthma Sales, Revenue and Growth Rate (2015-2020) 12.4 Food Allergy Sales, Revenue and Growth Rate (2015-2020) 12.5 Venom Allergy Sales, Revenue and Growth Rate (2015-2020) 12.6 Others Sales, Revenue and Growth Rate (2015-2020) 13 Allergy Immunotherapy Market Forecast by Regions (2020-2026) 13.1 Global Allergy Immunotherapy Sales, Revenue and Growth Rate (2020-2026) 13.2 Allergy Immunotherapy Market Forecast by Regions (2020-2026) 13.2.1 North America Allergy Immunotherapy Market Forecast (2020-2026) 13.2.2 Europe Allergy Immunotherapy Market Forecast (2020-2026) 13.2.3 Asia-Pacific Allergy Immunotherapy Market Forecast (2020-2026) 13.2.4 Middle East and Africa Allergy Immunotherapy Market Forecast (2020-2026) 13.2.5 South America Allergy Immunotherapy Market Forecast (2020-2026) 13.3 Allergy Immunotherapy Market Forecast by Types (2020-2026) 13.4 Allergy Immunotherapy Market Forecast by Applications (2020-2026) 13.5 Allergy Immunotherapy Market Forecast Under COVID-19 14 Appendix 14.1 Methodology 14.2 Research Data Source
Inquiry For Buying
Allergy Immunotherapy
Request Sample
Allergy Immunotherapy
